A citation-based method for searching scientific literature

Maria C Katapodi, Valeria Viassolo, Maria Caiata-Zufferey, Christos Nikolaidis, Rosmarie Bührer-Landolt, Nicole Buerki, Rossella Graffeo, Henrik Csaba Horváth, Christian Kurzeder, Manuela Rabaglio, Michael Scharfe, Corinne Urech, Tobias E Erlanger, Nicole Probst-Hensch, Karl Heinimann, Viola Heinzelmann-Schwarz, Olivia Pagani, Pierre O Chappuis. JMIR Res Protoc 2017
Times Cited: 17







List of co-cited articles
89 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review.
Ravi N Sharaf, Parvathi Myer, Christopher D Stave, Lisa C Diamond, Uri Ladabaum. Clin Gastroenterol Hepatol 2013
88
35

Testing participation in BRCA1/2-positive families: initiator role of index cases.
Cécile Blandy, Françoise Chabal, Dominique Stoppa-Lyonnet, Claire Julian-Reynier. Genet Test 2003
47
29



Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers.
Julia Fehniger, Feng Lin, Mary S Beattie, Galen Joseph, Celia Kaplan. J Genet Couns 2013
51
29



Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
23

Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative.
Jennifer L Caswell-Jin, Anjali D Zimmer, Will Stedden, Kerry E Kingham, Alicia Y Zhou, Allison W Kurian. J Natl Cancer Inst 2019
53
23

A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.
David Cella, Chanita Hughes, Amy Peterman, Chih-Hung Chang, Beth N Peshkin, Marc D Schwartz, Lari Wenzel, Amy Lemke, Alfred C Marcus, Caryn Lerman. Health Psychol 2002
175
23

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014
367
23

How communication of genetic information within the family is addressed in genetic counselling: a systematic review of research evidence.
Álvaro Mendes, Milena Paneque, Liliana Sousa, Angus Clarke, Jorge Sequeiros. Eur J Hum Genet 2016
39
17

The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety.
Erica Sermijn, Liesbeth Delesie, Ellen Deschepper, Ingrid Pauwels, Maryse Bonduelle, Erik Teugels, Jacques De Grève. Fam Cancer 2016
34
17


Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
Diana Mandelker, Liying Zhang, Yelena Kemel, Zsofia K Stadler, Vijai Joseph, Ahmet Zehir, Nisha Pradhan, Angela Arnold, Michael F Walsh, Yirong Li,[...]. JAMA 2017
227
17

Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.
Erna Claes, Gerry Evers-Kiebooms, Andrea Boogaerts, Marleen Decruyenaere, Lieve Denayer, Eric Legius. Am J Med Genet A 2003
163
17

Outcomes of a randomised controlled trial of a complex genetic counselling intervention to improve family communication.
Jan Hodgson, Sylvia Metcalfe, Clara Gaff, Susan Donath, Martin B Delatycki, Ingrid Winship, Loane Skene, MaryAnne Aitken, Jane Halliday. Eur J Hum Genet 2016
44
17

Increased genetic counseling support improves communication of genetic information in families.
Laura E Forrest, Jo Burke, Sonya Bacic, David J Amor. Genet Med 2008
67
17

Quantifying family dissemination and identifying barriers to communication of risk information in Australian BRCA families.
Emma Healey, Natalie Taylor, Sian Greening, Claire E Wakefield, Linda Warwick, Rachel Williams, Kathy Tucker. Genet Med 2017
21
17

Supporting disclosure of genetic information to family members: professional practice and timelines in cancer genetics.
Benjamin Derbez, Antoine de Pauw, Dominique Stoppa-Lyonnet, Sandrine de Montgolfier. Fam Cancer 2017
15
20

Development of a Web-based Family Intervention for BRCA Carriers and Their Biological Relatives: Acceptability, Feasibility, and Usability Study.
Maria C Katapodi, Miyeon Jung, Ann M Schafenacker, Kara J Milliron, Kari E Mendelsohn-Victor, Sofia D Merajver, Laurel L Northouse. JMIR Cancer 2018
14
21

Delivery Of Cascade Screening For Hereditary Conditions: A Scoping Review Of The Literature.
Megan C Roberts, W David Dotson, Christopher S DeVore, Erica M Bednar, Deborah J Bowen, Theodore G Ganiats, Ridgely Fisk Green, Georgia M Hurst, Alisdair R Philp, Charité N Ricker,[...]. Health Aff (Millwood) 2018
65
17

Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors.
Beth Anderson, Jennifer McLosky, Elizabeth Wasilevich, Sarah Lyon-Callo, Debra Duquette, Glenn Copeland. J Cancer Epidemiol 2012
64
17


Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.
Brian Drohan, Constance A Roche, James C Cusack, Kevin S Hughes. Ann Surg Oncol 2012
67
17


Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
Leslie M Randall, Bhavana Pothuri, Elizabeth M Swisher, John P Diaz, Adam Buchanan, Catherine T Witkop, C Bethan Powell, Ellen Blair Smith, Mark E Robson, Jeff Boyd,[...]. Gynecol Oncol 2017
58
17

Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening.
Kenneth Offit, Kaitlyn A Tkachuk, Zsofia K Stadler, Michael F Walsh, Hector Diaz-Zabala, Jeffrey D Levin, Zoe Steinsnyder, Vignesh Ravichandran, Ravi N Sharaf, Melissa K Frey,[...]. J Clin Oncol 2020
20
17

Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.
Goli Samimi, Marcus Q Bernardini, Lawrence C Brody, Charlisse F Caga-Anan, Ian G Campbell, Georgia Chenevix-Trench, Fergus J Couch, Michael Dean, Joanne A de Hullu, Susan M Domchek,[...]. J Clin Oncol 2017
44
17

The future of clinical cancer genomics.
Kenneth Offit. Semin Oncol 2016
17
17

Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Marc D Schwartz, Heiddis B Valdimarsdottir, Beth N Peshkin, Jeanne Mandelblatt, Rachel Nusbaum, An-Tsun Huang, Yaojen Chang, Kristi Graves, Claudine Isaacs, Marie Wood,[...]. J Clin Oncol 2014
166
17

Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop.
Christos Nikolaidis, Chang Ming, Carla Pedrazzani, Tina van der Horst, Andrea Kaiser-Grolimund, Zanfina Ademi, Rosmarie Bührer-Landolt, Nicole Bürki, Maria Caiata-Zufferey, Victoria Champion,[...]. Public Health Genomics 2018
8
37

The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
Fred H Menko, Jacqueline A Ter Stege, Lizet E van der Kolk, Kiki N Jeanson, Winnie Schats, Daoud Ait Moha, Eveline M A Bleiker. Fam Cancer 2019
52
17

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
152
17

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
301
17

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
Douglas E Levy, Stacey D Byfield, Catherine B Comstock, Judy E Garber, Sapna Syngal, William H Crown, Alexandra E Shields. Genet Med 2011
170
17

Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
Deborah Cragun, Anne Weidner, Courtney Lewis, Devon Bonner, Jongphil Kim, Susan T Vadaparampil, Tuya Pal. Cancer 2017
108
17

Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.
Maria C Katapodi, Laurel L Northouse, Kara J Milliron, Guipeng Liu, Sofia D Merajver. Psychooncology 2013
18
17


Uptake of testing for BRCA1/2 mutations in South East Scotland.
Susan M Holloway, Birgitta Bernhard, Harry Campbell, Wayne W K Lam. Eur J Hum Genet 2008
11
18

Counselling framework for moderate-penetrance cancer-susceptibility mutations.
Nadine Tung, Susan M Domchek, Zsofia Stadler, Katherine L Nathanson, Fergus Couch, Judy E Garber, Kenneth Offit, Mark E Robson. Nat Rev Clin Oncol 2016
179
11

Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial.
Susan V Montgomery, Andrea M Barsevick, Brian L Egleston, Ruth Bingler, Karen Ruth, Suzanne M Miller, John Malick, Terrence P Cescon, Mary B Daly. Fam Cancer 2013
53
11

Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain.
Judit Sanz, Teresa Ramón y Cajal, Asunción Torres, Esther Darder, Neus Gadea, Angela Velasco, Daniel Fortuny, Consol López, David Fisas, Joan Brunet,[...]. Fam Cancer 2010
20
11

An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations.
Paboda Ratnayake, Claire E Wakefield, Bettina Meiser, Graeme Suthers, Melanie A Price, Jessica Duffy, Kathy Tucker. Fam Cancer 2011
24
11

A Pilot study of the Sharing Risk Information Tool (ShaRIT) for Families with Hereditary Breast and Ovarian Cancer Syndrome.
Ani Kardashian, Julia Fehniger, Jennifer Creasman, Eleanor Cheung, Mary Stanley Beattie. Hered Cancer Clin Pract 2012
21
11


BRCA1/2 predictive testing: a study of uptake in two centres.
Lucy Brooks, Fiona Lennard, Andrew Shenton, Fiona Lalloo, Ingrid Ambus, Audrey Ardern-Jones, Rachel Belk, Bronwyn Kerr, David Craufurd, Rosalind Eeles,[...]. Eur J Hum Genet 2004
43
11

All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results.
Chanita Hughes, Caryn Lerman, Marc Schwartz, Beth N Peshkin, Lari Wenzel, Steven Narod, Camille Corio, Kenneth P Tercyak, Danielle Hanna, Claudine Isaacs,[...]. Am J Med Genet 2002
156
11

Intrafamilial disclosure of risk for hereditary breast and ovarian cancer: points to consider.
Lee Black, Kelly A McClellan, Denise Avard, Bartha Maria Knoppers. J Community Genet 2013
16
12

The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation.
E Sermijn, G Goelen, E Teugels, L Kaufman, M Bonduelle, B Neyns, B Poppe, A De Paepe, J De Grève. J Med Genet 2004
46
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.